Showing results (41-50 of 72) with videos related to
Sort By:
Pageof 8
Cell Death & Disease|July 13, 2019
Discovery of N-phenyl-(2,4-dihydroxypyrimidine-5-sulfonamido) phenylurea-based thymidylate synthase (TS) inhibitor as a novel multi-effects antitumor drugs with minimal toxicityXin-Yang Li, Ting-Jian Zhang, Mohamed Olounfeh Kamara, et al.European Journal of Medicinal Chemistry|October 20, 2024
Design, synthesis and biological evaluation of novel benzimidazole-derived p21-activited kinase 4 (PAK4) inhibitors bearing a 4-(4-methylpiperazin-1-yl)phenyl scaffold as potential antitumor agentsShuang Hao, Liang Hou, Jia-Hui Wang, et al.Bioorganic & Medicinal Chemistry Letters|January 30, 2017
Discovery and biological evaluation of some (1H-1,2,3-triazol-4-yl)methoxybenzaldehyde derivatives containing an anthraquinone moiety as potent xanthine oxidase inhibitorsTing-Jian Zhang, Song-Ye Li, Wei-Yan Yuan, et al.Bioorganic Chemistry|January 25, 2026
TRK inhibitors in cancer therapeutics: Recent advances and future perspectivesHong-Ye Liu, Ying-Hao Sun, Yan-Ping Wang, et al.Journal of Pharmaceutical and Biomedical Analysis|March 17, 2019
A validated UHPLC-MS/MS method for measurement of pharmacokinetics and tissue distribution of trolline in ratNan Zhao, Qi Sun, Kamara Mohamed Olounfeh, et al.International Journal of Molecular Sciences|March 23, 2018
Study of Imidazolium Salt Derivatives as PIK3CA Inhibitors Using a Comprehensive in Silico MethodMing-Yang Wang, Jing-Wei Liang, Xin-Yang Li, et al.European Journal of Medicinal Chemistry|July 12, 2023
Discovery of novel thymidylate synthase (TS) inhibitors that influence cancer angiogenesis and metabolic reprogramming in NSCLC cellsGang Dong, Yu-Heng Li, Jing-Si Guo, et al.Bioorganic Chemistry|September 5, 2020
Design, synthesis and biological evaluation of novel (E)-N-phenyl-4-(pyridine-acylhydrazone) benzamide derivatives as potential antitumor agents for the treatment of multiple myeloma (MM)Xin-Yang Li, Shuai Li, Guo-Qing Lu, et al.European Journal of Medicinal Chemistry|December 19, 2020
Design, synthesis, and in vitro and in vivo anti-angiogenesis study of a novel vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor based on 1,2,3-triazole scaffoldDe-Pu Wang, Kai-Li Liu, Xin-Yang Li, et al.Bioorganic Chemistry|August 7, 2024
Design, synthesis and biological evaluation of novel quinazoline-derived EGFR/HER-2 dual-target inhibitors bearing a heterocyclic-containing tail as potential anti-tumor agentsShuang Hao, Jia-Hui Wang, Liang Hou, et al.Pageof 8